Skip to main content
Top
Published in: neurogenetics 4/2008

01-10-2008 | Original Article

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease

Authors: Jung Mi Choi, Myoung Soo Woo, Hyeo-Il Ma, Suk Yun Kang, Young-Hee Sung, Seok Woo Yong, Sun Ju Chung, Joong-Seok Kim, Hae-won Shin, Chul Hyoung Lyoo, Phil Hyu Lee, Jong Sam Baik, Sang-Jin Kim, Mee Young Park, Young Ho Sohn, Jin-Ho Kim, Jae Woo Kim, Myung Sik Lee, Myoung Chong Lee, Dong-Hyun Kim, Yun Joong Kim

Published in: Neurogenetics | Issue 4/2008

Login to get access

Abstract

Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic causes of Parkinson disease (PD). Recently, G2385R substitution in LRRK2 has been determined as a susceptibility allele in Asian PD. The objective of this study is to determine the frequency of mutations in these PARK genes in a Korean early-onset Parkinson disease (EOPD) cohort. The authors sequenced 35 exons in SNCA, PARKIN, DJ-1, PINK1, and LRRK2 in 72 unrelated EOPD (age-at-onset ≤50) recruited from ten movement disorders clinics in South Korea. Gene dosage change of the aforementioned genes was studied using multiple ligation-dependent probe amplification. We found four patients with PARKIN mutations, which were homozygous deletion of exon 4, compound heterozygous deletion of exon 2 and exon 4, heterozygous deletion of exon 4, and heterozygous nonsense mutation (Q40X). Four patients had PINK1 mutations; a compound heterozygous mutation (N367S and K520RfsX522) and three heterozygous mutations (G32R, R279H, and F385L). A missense mutation of SNCA (A53T) was found in a familial PD with autosomal dominant inheritance. Nine patients (12.5%) had heterozygous G2385R polymorphism of LRRK2, whereas none had G2019S mutation. However, no mutations were detected in DJ-1 and UCHL1 in our series. We identified genetic variants in PARKIN, PINK1, LRRK2, and SNCA as a cause or genetic risk factors for PD in 25% of Korean EOPD, and mutation of PARKIN was the most common genetic cause.
Literature
3.
5.
go back to reference Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M et al (2008) Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol 8:1 doi:10.1186/1471-2377-8-1 PubMedCrossRef Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M et al (2008) Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol 8:1 doi:10.​1186/​1471-2377-8-1 PubMedCrossRef
8.
go back to reference Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMed Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMed
9.
go back to reference Choi JM, Woo MS, Kim SM, Ma HI, Sung YH, Lee PH et al (2008) Trinucleotide repeats number in SCA2, SCA3 and SCA17 in early-onset Parkinson’s disease. J Korean Neurol Assoc 26:23–27 Choi JM, Woo MS, Kim SM, Ma HI, Sung YH, Lee PH et al (2008) Trinucleotide repeats number in SCA2, SCA3 and SCA17 in early-onset Parkinson’s disease. J Korean Neurol Assoc 26:23–27
10.
go back to reference Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708–1714 doi:10.1002/mds.21370 PubMedCrossRef Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708–1714 doi:10.​1002/​mds.​21370 PubMedCrossRef
11.
go back to reference Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson’s disease gene rearrangements. Mov Disord 22:2274–2278 doi:10.1002/mds.21532 PubMedCrossRef Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson’s disease gene rearrangements. Mov Disord 22:2274–2278 doi:10.​1002/​mds.​21532 PubMedCrossRef
13.
go back to reference Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics 7:133–138 doi:10.1007/s10048-006-0041-5 PubMedCrossRef Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics 7:133–138 doi:10.​1007/​s10048-006-0041-5 PubMedCrossRef
15.
16.
go back to reference Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525 doi:10.1002/humu.9240 PubMedCrossRef Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525 doi:10.​1002/​humu.​9240 PubMedCrossRef
17.
go back to reference Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941 doi:10.1002/ana.410440612 PubMedCrossRef Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941 doi:10.​1002/​ana.​410440612 PubMedCrossRef
18.
23.
25.
go back to reference Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K et al (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 63:833–838 doi:10.1001/archneur.63.6.833 PubMedCrossRef Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K et al (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 63:833–838 doi:10.​1001/​archneur.​63.​6.​833 PubMedCrossRef
26.
go back to reference Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61:47–54 doi:10.1002/ana.21039 PubMedCrossRef Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61:47–54 doi:10.​1002/​ana.​21039 PubMedCrossRef
27.
go back to reference Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649–1656 doi:10.1093/hmg/10.16.1649 PubMedCrossRef Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649–1656 doi:10.​1093/​hmg/​10.​16.​1649 PubMedCrossRef
28.
go back to reference Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson’s disease. Can J Neurol Sci 34:53–55PubMed Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson’s disease. Can J Neurol Sci 34:53–55PubMed
29.
go back to reference Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918–921 doi:10.1002/ana.20484 PubMedCrossRef Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918–921 doi:10.​1002/​ana.​20484 PubMedCrossRef
Metadata
Title
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
Authors
Jung Mi Choi
Myoung Soo Woo
Hyeo-Il Ma
Suk Yun Kang
Young-Hee Sung
Seok Woo Yong
Sun Ju Chung
Joong-Seok Kim
Hae-won Shin
Chul Hyoung Lyoo
Phil Hyu Lee
Jong Sam Baik
Sang-Jin Kim
Mee Young Park
Young Ho Sohn
Jin-Ho Kim
Jae Woo Kim
Myung Sik Lee
Myoung Chong Lee
Dong-Hyun Kim
Yun Joong Kim
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Neurogenetics / Issue 4/2008
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-008-0138-0

Other articles of this Issue 4/2008

neurogenetics 4/2008 Go to the issue